Fatty acid synthase inhibition induces differential expression of genes involved in apoptosis and cell proliferation in ocular cancer cells

Nutrition and Cancer

Volumn 65, Issue 2, 2013, Pages 311-316

  Deepa, Perinkulam Ravi ^a   Vandhana, Suryanarayanan ^a,b   Krishnakumar, Subramanian ^b  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

^b VISION RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CERULENIN; COMPLEMENTARY DNA; CYTOCHROME C; FATTY ACID SYNTHASE; S PHASE KINASE ASSOCIATED PROTEIN 2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INVASION; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL MEDIATED CYTOTOXICITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EYE CANCER; FATTY ACID SYNTHESIS; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA; UPREGULATION;

ACETYL-COA CARBOXYLASE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CERULENIN; CYTOCHROMES C; FATTY ACID SYNTHASE, TYPE I; FATTY ACID SYNTHESIS INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPID METABOLISM; PPAR ALPHA; PPAR GAMMA; RETINAL NEOPLASMS; RETINOBLASTOMA; S-PHASE KINASE-ASSOCIATED PROTEINS;

EID: 84874587576     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.748923     Document Type: Article

References (25)

1. Kuhajda FP: Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16, 202-208, 2000.
2. Menendez JA and Lupu R: Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7, 763-777, 2007.
3. Saati GE and Archer MC: Inhibition of fatty acid synthase and Sp1 expression by 3, 3-Diindolylmethane in human breast cancer cells. Nutrition and Cancer 63, 790-794, 2011.
4. Tomek K, Wagner R, Varga F, Singer CF, Karlic H, et al.: Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer. Mol Cancer Res, 9, 1767-1779, 2011.
5. Finger PT, Harbour JW, and Karcioglu ZA: Risk factors for metastasis in retinoblastoma. Surv Ophthalmol, 47, 1-16, 2002.
6. Vandhana S, Deepa PR, Jayanthi U, Biswas J, andKrishnakumar S: Clinicopathological correlations of fatty acid synthase expression in retinoblastoma: an Indian cohort study. Exp Mol Pathol 90, 29-37, 2011.
7. Biswas J, Das D, Krishnakumar S, and Shanmugam MP: Histopathologic analysis of 232 eyes with retinoblastoma conducted in an Indian tertiarycare ophthalmic center. J Pediatr Ophthalmol Strabismus 40, 265-267, 2003.
8. Kandalam M, MitraM, Subramanian K, and Biswas J:Molecular pathology of retinoblastoma. Middle East Afr J Ophthalmol, 17, 217-223, 2010.
9. Ho TS, Ho YP, Wong WY, Chi-Ming Chiu L, Wong YS, et al.: Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspasedependent apoptosis in human melanoma A-375 cells. Biomed Pharmacother, 61, 578-587, 2007.
10. LiuX, Shi Y, Giranda VL, and LuoY: Inhibition of the phosphatidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosis. Mol Cancer Ther 5, 494-501, 2006.
11. Pizer ES, Chrest FJ, DiGiuseppe JA, and Han WF: Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res 58, 4611-4615, 1998.
12. Migita T, Ruiz S, Fornari A, Fiorentino M, Priolo C, et al.: Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst 101, 519-532, 2009.
13. Lu S and Archer MC: Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer. Carcinogenesis 26, 153-157, 2005.
14. Knowles LM, Axelrod F, Browne CD, and Smith JW: A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating Skp2. J Biol Chem 279, 30540-30545, 2004.
15. Deepa PR, Vandhana S, Jayanthi U, and Krishnakumar S: Therapeutic and toxicological evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells. Basic Clin Pharmacol Toxicol, 110, 494-503, 2012.
16. Vazquez-Martin A, Moreno G, Colomer R, Menendez JA, Ropero S, et al.: Microarray gene expression analysis of fatty acid synthase (FAS) signaling on breast cancer cell lines. Journal of Clinical Oncology, 22, 9690, 2004.
17. Wei N, Wang B, Zhang QY, Mi MT, Zhu JD, et al.: Effects of different dietary fatty acids on the fatty acid compositions and the expression of lipid metabolic-related genes in mammary tumor tissues of rats. Nutrition and Cancer, 60, 810-825, 2008.
18. Baron A, Migita T, Tang D, and Loda M: Fatty acid synthase: a metabolic oncogene in prostate cancer? J Cell Biochem 91, 47-53, 2004.
19. Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, et al.: International Union of Pharmacology: 61. Peroxisome proliferator-activated receptors. Pharmacol Rev 58, 726-741, 2006.
20. Issemann I, Prince RA, Tugwood JD, and Green S: The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J Mol Endocrinol 11, 37-47, 1993.
21. Li JN, Gorospe M, Chrest FJ, Kumaravel TS, Evans MK, et al.: Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res 61, 1493-1499, 2001.
22. Heiligtag SJ, Bredehorst R, and David KA: Key role of mitochondria in cerulenin-mediated apoptosis. Cell Death Differ 9, 1017-1025, 2002.
23. Roulin D, Cerantola Y, Dormond-Meuwly A, Demartines N, and Dormond O: Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo. Mol Cancer, 9, 57, 2010.
24. Rojanathammanee L, Harmon EB, Grisanti LA, Govitrapong P, Ebadi M, et al.: The 27-kDa heat shock protein confers cytoprotective effects through a beta 2-adrenergic receptor agonist-initiated complex with beta-arrestin. Mol Pharmacol 75, 855-865, 2009.
25. Hu ZQ, Zhang JY, Ji CN, Xie Y, Chen JZ, et al.: Grb10 interacts with Bim L and inhibits apoptosis. Mol Biol Rep 37, 3547-3552, 2010.